Caladrius Biosciences Inc (CLBS):企業の財務・戦略的SWOT分析

◆英語タイトル:Caladrius Biosciences Inc (CLBS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81649FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥80,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥120,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc, is a clinical-stage biopharmaceutical company. The company develops cellular therapies for the treatment cardiovascular indications and autoimmune diseases. The company’s products pipeline includes CLBS03 is an autologous ex vivo polyclonal T regulatory cell clinical phase 2 therapy used in the treatment of type 1 diabetes mellitus. Its other product candidates include HONEDRA used in the treatment of critical limb ischemia; and CLBS14 used in the treatment of no-option refractory disabling angina (NORDA); CLBS16 for treating coronary microvascular dysfunction (CMD) and CLBS119 for repair of COVID-19 induced lung damage treatment. The company offers T regulatory technology and CD34+ technology. Caladrius serves biotechnology, pharmaceutical and medical product companies, and academic research institutions. The company operates in Basking Ridge, Irvine and New York, the US. Caladrius is headquartered in Basking Ridge, New Jersey, the US.

Caladrius Biosciences Inc Key Recent Developments

Feb 25,2021: Caladrius Biosciences reports fourth quarter and full year 2020 financial results and provides business update
Feb 18,2021: Caladrius Biosciences to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Thursday, February 25, 2021 at 4:30 p.m. Eastern Time
Jan 25,2021: Caladrius Biosciences Closes $25.0 Million Private Placement
Jan 21,2021: Caladrius Biosciences Announces $25.0 Million Private Placement
Jan 06,2021: Caladrius Biosciences Announces Participation in Upcoming Virtual Investor Conferences in January 2021

This comprehensive SWOT profile of Caladrius Biosciences Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Caladrius Biosciences Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Caladrius Biosciences Inc – Key Information
Caladrius Biosciences Inc – Overview
Caladrius Biosciences Inc – Key Employees
Caladrius Biosciences Inc – Key Employee Biographies
Caladrius Biosciences Inc – Key Operational Heads
Caladrius Biosciences Inc – Major Products and Services
Caladrius Biosciences Inc – History
Caladrius Biosciences Inc – Company Statement
Caladrius Biosciences Inc – Locations And Subsidiaries
Caladrius Biosciences Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Caladrius Biosciences Inc – Business Description
Caladrius Biosciences Inc – Corporate Strategy
Caladrius Biosciences Inc – SWOT Analysis
SWOT Analysis – Overview
Caladrius Biosciences Inc – Strengths
Caladrius Biosciences Inc – Weaknesses
Caladrius Biosciences Inc – Opportunities
Caladrius Biosciences Inc – Threats
Caladrius Biosciences Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Caladrius Biosciences Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Caladrius Biosciences Inc, Key Information
Caladrius Biosciences Inc, Key Ratios
Caladrius Biosciences Inc, Share Data
Caladrius Biosciences Inc, Major Products and Services
Caladrius Biosciences Inc, History
Caladrius Biosciences Inc, Key Employees
Caladrius Biosciences Inc, Key Employee Biographies
Caladrius Biosciences Inc, Key Operational Heads
Caladrius Biosciences Inc, Other Locations
Caladrius Biosciences Inc, Subsidiaries
Caladrius Biosciences Inc, Key Competitors
Caladrius Biosciences Inc, SWOT Analysis
Caladrius Biosciences Inc, Ratios based on current share price
Caladrius Biosciences Inc, Annual Ratios
Caladrius Biosciences Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Caladrius Biosciences Inc (CLBS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MBDA Holdings SAS:企業の戦略・SWOT・財務情報
    MBDA Holdings SAS - Strategy, SWOT and Corporate Finance Report Summary MBDA Holdings SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Mecklenburg Electric Cooperative:企業の戦略的SWOT分析
    Mecklenburg Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Salt Lake Potash Ltd (SO4):企業の財務・戦略的SWOT分析
    Summary Salt Lake Potash Ltd (Salt Lake Potash), formerly Wildhorse Energy Ltd, is a mining and mineral exploration and development company that develops and evaluates underground coal gasification projects and uranium deposits. The company operates exploration and mining activities with geographic …
  • Immunovia AB (IMMNOV):企業の財務・戦略的SWOT分析
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • Esperite NV (ESP):企業の財務・戦略的SWOT分析
    Esperite NV (ESP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • M3, Inc. (2413):企業の財務・戦略的SWOT分析
    M3, Inc. (2413) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Editas Medicine Inc (EDIT):製薬・医療:M&Aディール及び事業提携情報
    Summary Editas Medicine Inc (Editas Medicine) formerly Gengine Inc, is a discovery stage biotechnology company that develops genome level treatments for rare diseases. The company is developing a proprietary genome editing platform based on its in-licensed clustered regularly interspaced short palin …
  • Aurobindo Pharma Ltd (AUROPHARMA)-製薬・医療分野:企業M&A・提携分析
    Summary Aurobindo Pharma Ltd (Aurobindo Pharma) is a pharmaceutical company which develops, manufactures and exports formulations and active pharmaceutical ingredients (API's). Its products portfolio include active pharma ingredients, formulations, antibiotics, anti-retrovirals, anti- allergics, gas …
  • Manulife (International) Limited:企業の戦略・SWOT・財務情報
    Manulife (International) Limited - Strategy, SWOT and Corporate Finance Report Summary Manulife (International) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • BKW AG (BKW)-エネルギー分野:企業M&A・提携分析
    Summary BKW AG (BKW) is a provider of energy services. The company plans, builds and operates infrastructure to produce and supply energy. It generates electricity from varied fuel sources such as hydro, nuclear, fossil, and renewable sources primarily, wind and small hydro, besides solar and biomas …
  • Minnkota Power Cooperative Inc:企業の戦略的SWOT分析
    Minnkota Power Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • S-Oil Corporation Inc (010950):企業の財務・戦略的SWOT分析
    S-Oil Corporation Inc (010950) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Aceto Corp (ACET):企業の財務・戦略的SWOT分析
    Aceto Corp (ACET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cheng Shin Rubber Ind. Co Ltd (2105):企業の財務・戦略的SWOT分析
    Cheng Shin Rubber Ind. Co Ltd (2105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • The Andersons Inc (ANDE):企業の財務・戦略的SWOT分析
    The Andersons Inc (ANDE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Busan Bank Co., Ltd.:企業の戦略・SWOT・財務情報
    Busan Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Busan Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • KCOM Group PLC (KCOM):企業の財務・戦略的SWOT分析
    Summary KCOM Group PLC (KCOM) is a technology company that provides communication and information technology services. The company provides IT and integration services, including cloud-based infrastructure and contact and collaboration solutions. It offers broadband and telephony services for consum …
  • International Games System Co Ltd:企業の戦略・SWOT・財務分析
    International Games System Co Ltd - Strategy, SWOT and Corporate Finance Report Summary International Games System Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Centrica Plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Centrica Plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Centrica Plc (Centrica) is an integrated energy company. It carries out electricity generation through and combined cycle gas turbine (CCGT) power stations, and nuclear power plants through its stake in EDF …
  • SRI International:企業のM&A・事業提携・投資動向
    SRI International - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SRI International Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆